Moran ben David

Directeur/Membre du Conseil chez Immunyx Pharma Ltd.

Profil

As Chief Business Development Officer at VLX, Moran brings with her a rich interdisciplinary background and skills at the cross-section of pharma drug development, biology and business and IP law from blockbuster-drugs IP litigation, to evaluation of new technologies, biological and business opportunities as well as management of collaborations worldwide.
Prior to joining VLX, Moran was Head of Business Development at Pharma Two B in Israel and held various business, strategy, and technological leadership positions in global strategic partnership and alliance management at GlaxoSmithKline, Novartis, and Takeda in Boston.
Moran is seasoned in establishing partnerships for early stage innovative projects and clinical development.
Before joining the pharmaceutical industry, Moran was a practicing lawyer, specializing in patent litigation for pharmaceutical companies.
Moran holds a BS in Biology from Tel Aviv University, a dual degree from IDC in Finance and Law, and an MBA from Boston University.

Postes actifs de Moran ben David

Sociétés	Poste	Début
Immunyx Pharma Ltd.	Directeur/Membre du Conseil	01/04/2021
Van Leer Xenia Ventures	Corporate Officer/Principal	01/07/2019

Anciens postes connus de Moran ben David

Sociétés	Poste	Fin
GSK PLC	Directeur/Membre du Conseil	02/05/2017
NOVARTIS AG	Directeur/Membre du Conseil	02/08/2016

Formation de Moran ben David

Questrom School of Business	Masters Business Admin
Tel-Aviv University	Undergraduate Degree